• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Trump Administration
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    Kuwaiti fund manager, companies that lost money on Vioxx now suing Merck for fraud
    Healthcare

    Kuwaiti fund manager, companies that lost money on Vioxx now suing Merck for fraud

    Jessica Karmasek -
    February 3, 2015 6:45 pm
    0
    (iStock)
    Healthcare

    How Medicare can join the war on drugs

    Devon Herrick -
    December 19, 2014 10:00 am
    0
    Bipartisan Senate proposal aims to fast-track Ebola vaccines
    Healthcare

    Bipartisan Senate proposal aims to fast-track Ebola vaccines

    Sean Lengell -
    October 29, 2014 12:47 am
    0
    It's in an FDA official's self-interest to err on the side of over-caution in approving new drugs. (iStock)
    Columnists

    Officially killing Americans

    Walter Williams -
    October 13, 2014 8:49 pm
    0
    Critics don't dispute the drug's effectiveness, they take issue with the cost: $1,000 per pill.
    Business

    America’s other drug war

    Philip Klein -
    September 22, 2014 9:00 am
    0
    The economics of American healthcare are dictated by the Golden Rule:
    Economy

    Cheaper drugs can also mean less choice without savings for patients

    Peter Pitts -
    September 10, 2014 9:00 am
    0
    White House asks for $30M for CDC’s Ebola efforts
    News

    White House asks for $30M for CDC’s Ebola efforts

    Andrew Taylor -
    September 5, 2014 11:40 pm
    0
    Glenn Adam Chin, left, a former supervisory pharmacist at the New England Compounding Center, walks with his attorney Paul Shaw, right, after appearing in federal court, Thursday, Sept. 4, 2014, in Boston. The pharmacy, which custom-mixed medications in bulk, has been blamed for a 2012 outbreak of fungal meningitis that killed 64 people. Chin was charged with one count of mail fraud, but federal prosecutors said it is part of a larger criminal investigation of Chin and others. (AP Photo/Steven Senne)
    Business

    Pharmacist arrested in tainted steroid case

    Denise Lavoie -
    September 5, 2014 3:04 am
    0
    FILE - In this Thursday, Feb. 28, 2013 file photo, a Merck logo is placed on scientist's lab coat in West Point, Pa. The Food and Drug Administration on Thursday, Sept. 4, 2014 said it has granted accelerated approval to Merck's Keytruda, for treating melanoma that's spread or can't be surgically removed, in patients previously treated with another drug. (AP Photo/Matt Rourke, File)
    Business

    FDA OKs Merck drug, 1st in new cancer drug class

    Linda Johnson -
    September 4, 2014 9:41 pm
    0
    Highmark sues UPMC over billing for cancer drugs
    Business

    Highmark sues UPMC over billing for cancer drugs

    Washington Examiner -
    September 4, 2014 7:08 pm
    0
    1...143144145...154Page 144 of 154
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter